90
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and Persistent Cough in Children

Pages 281-286 | Published online: 08 Jul 2009

  • Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergård T. How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J 1993; 12: 284–8.
  • Heininger U, Klemens S, Schmitt-Grohe S, Lorenz C, Rost R, Christenson P, et al. Clinical characteristics of Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13: 306–9.
  • Mastrantonio P, Stefanelli P, Giuliano M, Herrera Rojas Y, Ciofi degli Atti M, et al. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J Clin Microbiol 1998; 36: 999–1002.
  • Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349–55.
  • Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. Efficacy trial of acellular pertussis vaccine. Technical Report, Trial I. SMI-tryck 1995; 105: 1–70.
  • Saikku P. Atypical respiratory pathogens. Clin Microbiol Infect 1997; 3: 599–604.
  • McGregor K, Chang BJ, Mee BJ, Riley TV. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis 1998; 17: 219–34.
  • Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17 (Suppl 1): S37–46.
  • Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. Erythromycin ethylsuccinate. Pediatr Infect Dis 1995; 14: 471–7.
  • Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol 1993; 31: 50–2.
  • Regan J and Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977; 6: 303–9.
  • Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Möllby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995; 183: 279–90.
  • Gnarpe J, Eriksson K. Sample preparation for Chlamydia pneumoniae PCR. APMIS 1995; 103: 307–8.
  • Tong CYW, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993; 46: 313–7.
  • Bernet C, Garret M, de Barbeyrac B, Bebear C, Bonnet J. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol 1989; 27: 2492–6.
  • von König CHW, Rott H, Bogaerts H, Schmitt HJ. A serological study of organisms possbly associated with pertussis-like coughing. Pediatr Infect Dis J 1998; 17: 645–9.
  • Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 1997; 350: 1569–77.
  • Lund-Olsen I, Lundbäck A, Gnarpe J, Gnarpe H. Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections. Acta Pediatr 1994; 83: 1143–5.
  • Grayston JT. Chlamydia pneumoniae (TWAR) infections in children. Pediatr Inf Dis J 1994; 13: 675–5.
  • Normann E, Gnarpe J, Gnarpe H, Wettergren B. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 1998; 87: 23–7.
  • Normann E, Gnarpe J, Gnarpe H, Wettergren B. Chlamydia pneumoniae in children attending day-care centers in Gävle, Sweden. Pediatr Infect Dis J 1998; 17: 474–8.
  • Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis J 1997; 16: 549–54.
  • Gnarpe J, Gnarpe H, Sundelöf B. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons. Scand J Infect Dis 1991; 23: 387–8.
  • Gnarpe J, Lundbäck A, Sundelöf B, Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 1992; 24: 161–4.
  • WHO meeting on case definition of pertussis: Geneva, 10–11 January 1991. Geneva: World Health Organization, 1991: 4–5 (Issue no. MIN/EPI/PERT/91.1.
  • Stehr K, Cherry JD, Heininger U, Schmitt-Grohe’ S, Uberall M, Laussucq S, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DtaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 1998; 101: 1–11.
  • Trollfors B, Taranger J, Lagergård T. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995; 333: 1045–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.